Atomwise has raised $168M across 1 funding round, plus 1 undated round. The company is valued at $320M.
Atomwise is backed by Google Ventures and Khosla Ventures, and in 2020 it raised $123 million to accelerate its AI-driven drug discovery work.
1 funding round, the latest highlighted.
Atomwise was founded in 2012, United States.
No date is disclosed for this round.
No filing has been made.
1 dated round, newest first.
DCVCLEADBB Capital GroupLEAD
Sanabil InvestmentsLEAD
Google Ventures
Khosla VenturesNo. Atomwise is a private company; its shares do not trade on a public exchange.
The last valuation is $320M.
Lead investors for each round are in the funding timeline.
The closest biotechnology / ai drug discovery peers are on the competitors page.
The routes section explains what is realistically available for a company at this stage.
Perpetual markets for stocks, gold, indices and pre-IPO names — settled on-chain, no wallet-to-exchange transfers.
